Scanning thru the D/M News, I see that D/M named a new president of their Radiopharmaceuticals Division. A Mr. Richard R. Dolighan, who was previously Group Vice Pres. and GM, NA for ICN Pharm., Inc.
Excerpt from the 3/11/98 press release :
"Formed in 1991 as a partnership between DuPont (NYSE:DD) and Merck & Co., Inc. (NYSE:MRK), DuPont Merck is a leader in radiopharmaceuticals, with a broad product line that includes Cardiolite(R), Mariluma (TM), Quadramet (R), and I.V. Persantine(R)."
That's tow mentions from D/M press releases in the past two weeks. |
